The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.

Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

“This state-of-the-art Kilkenny facility will have the highest production of Libre sensors in the world to help meet the ...

The site is a global manufacturing centre of excellence for Abbott’s diabetes care business and will employ more than 800 ...

The new facility is part of a €440m investment made by Abbott in Ireland. The initial announcement was made back in 2022.

Taoiseach Simon Harris and Abbott Chairman and Chief Executive Officer, Robert Ford, at the official opening of the ...

US medtech giant Abbott has officially opened a new manufacturing facility in Kilkenny, which will employ 800 people. The ...